Market Trends– category –
-
Lonza Expands US Manufacturing with New Spray Drying Facility; Samsung Biologics Secures $262M European CDMO Deal
Endpoints News Switzerland, South Korea, USA Overview Lonza announced a significant expansion of its U.S. manufacturing capabilities with a new commercial spray drying facility in Bend, Oregon, projected for completion by 2029 and creati... -
BIANCA CLINIC Pioneers Regenerative Medicine in Japan with Autologous Adipose Stem Cells and Exosome Therapy under Strict Regulatory Compliance
BIANCA CLINIC Japan Overview BIANCA CLINIC in Tokyo is advancing regenerative medicine by offering exosome therapy, purified stem cell culture supernatant, and autologous adipose-derived stem cell therapy, all strictly compliant with Jap... -
Northway Biotech Unveils €61M Personalized Medicine & CAR-T Manufacturing Plant in Lithuania, Accelerating European CGT Hub Formation
European Biotechnology Lithuania Overview CDMO Northway Biotech has invested €61 million to open a state-of-the-art cell therapy and personalized medicine center in Vilnius, Lithuania. The facility is actively pursuing GMP manufacturing ... -
Lonza to Build Large-Scale Commercial Spray-Drying Facility in Bend, Oregon, Enhancing US Drug Manufacturing Capacity by 2029
24/7 BIOPHARMA USA Overview Lonza, a leading CDMO, has announced plans for a large-scale commercial spray-drying facility in Bend, Oregon. This investment solidifies Lonza's position as a premier CDMO provider for commercial-scale spray-...
1